Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.13
Delayed Data
As of 11:03am ET
 -0.0694 / -3.15%
Today’s Change
2.09
Today|||52-Week Range
7.85
-32.85%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.20
Today’s open2.18
Day’s range2.09 - 2.18
Volume29,981
Average volume (3 months)50,965
Market cap$6.0M
Dividend yield--
Data as of 11:03am ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)-29.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book6.16

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc+0.05+3.40%
BVXVBiondVax Pharmaceuti...+0.00+0.00%
CYANCyanotech Corp+0.12+3.04%
ISRIsoRay Inc+0.02+3.83%
Data as of 11:03am ET, 02/23/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts


Search for Jobs